Rome, Italy

Menotti Calvani

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 62(Granted Patents)


Location History:

  • Pomezia, IT (2010)
  • Rome, IT (1982 - 2015)

Company Filing History:


Years Active: 1982-2015

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Menotti Calvani: Innovator in Medicinal Chemistry

Introduction

Menotti Calvani is a distinguished inventor based in Rome, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for diabetic complications. With a total of 12 patents to his name, Calvani's work has had a profound impact on patient care.

Latest Patents

Among his latest patents is a formulation of Acetyl L-carnitine for the preparation of a medicament aimed at preventing painful peripheral neuropathy in patients with type 2 diabetes. This innovative approach utilizes Acetyl L-carnitine, or one of its pharmaceutically acceptable salts, to alleviate symptoms such as pain, paraesthesia, or hyperaesthesia. The recommended administration is an oral dose of at least 3 grams per day, showcasing Calvani's commitment to improving the quality of life for those affected by this condition.

Career Highlights

Throughout his career, Menotti Calvani has worked with notable companies, including Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. His expertise in medicinal chemistry has led to advancements that benefit both patients and the medical community.

Collaborations

Calvani has collaborated with esteemed colleagues such as Claudio Cavazza and Luigi Mosconi. These partnerships have fostered innovation and have been instrumental in the development of his patented formulations.

Conclusion

Menotti Calvani's contributions to medicinal chemistry, particularly in the treatment of diabetic neuropathy, highlight his role as a leading inventor in the field. His ongoing work continues to inspire advancements in patient care and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…